NIH-funded research R21 grant

Understanding how importins regulate the NLRP6 inflammasome

Official title: Elucidating the novel mechanism of importins in NLRP6 inflammasome regulation

Funded at Washington University · NIH-10904635 · Data updated 2026-11-12

This study is looking at how certain proteins help control an important part of the immune system that can cause inflammation, with the hope of finding better treatments for chronic conditions like inflammatory bowel disease.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 10, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$194,375
NIH project number5R21AI173896-02
Project IDNIH-10904635 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals suffering from chronic inflammatory conditions, particularly inflammatory bowel disease.

Less likely to help

Patients with acute infections or those not suffering from chronic inflammatory diseases may not receive direct benefits from this research.

What this research studies

This research investigates the role of importins in regulating the NLRP6 inflammasome, which is crucial for the body's immune response. By examining how these proteins influence the activation of caspase-1 and the subsequent release of inflammatory cytokines, the study aims to uncover mechanisms that could lead to better treatments for chronic inflammatory diseases. The research involves biochemical assays and cellular models to explore the signaling pathways involved in inflammasome regulation. Patients may benefit from insights gained that could lead to targeted therapies for conditions like inflammatory bowel disease.

Why it matters

Potential benefit: If successful, this research could lead to new therapies for chronic inflammatory diseases by better understanding inflammasome regulation.

How similar studies have gone: Previous research has shown success in understanding inflammasome mechanisms, indicating that this approach has potential for meaningful advancements.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Shen, Chen — Washington University
  • Study coordinator: Shen, Chen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.